Financial statements Propharm Balakowska Raniszewska
Balance sheet of Propharm Balakowska Raniszewska
Company age:
Age:
6 y. 5 m. 4 d.
Balance sheet data of PROPHARM BALAKOWSKA RANISZEWSKA
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 6 524 523,19 | 6 497 109,75 |
| A. Fixed assets | 2 616 300,86 | 264 854,36 |
| B. Current assets | 3 908 222,33 | 6 232 255,39 |
| C. Share capital contributions (basic funds) | - | - |
| D. Own shares (stocks) | - | - |
| Total liabilities | 6 524 523,19 | 6 497 109,75 |
| A. Equity | -4 611 386,49 | -9 842 884,43 |
| B. Liabilities and provisions for liabilities | 11 135 909,68 | 16 339 994,18 |
| I. Long-term liabilities | 6 616 702,39 | 5 708 566,81 |
| II. Short-term liabilities | 4 408 478,82 | 10 459 007,48 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.